News
Feed
Events
Feed
News
+ Events
Feed

Kinarus Therapeutics Holding AG

  • ISIN CH0009115129
  • Land Switzerland

Aktuelle News

1 März 2024

18:36 Corporate EN

Kinarus Therapeutics Holding AG

Corporate
EN

Extraordinary General Meeting of Kinarus Holding approved all resolutions relating to the envisaged Business Combination with Curatis

28 Februar 2024

07:10 Ad-hoc EN

Kinarus Therapeutics Holding AG

Ad-hoc
EN

Publication of unaudited financial statements of Kinarus Therapeutics Holding AG (only) for FY2023

6 Februar 2024

07:10 Ad-hoc EN

Kinarus Therapeutics Holding AG

Ad-hoc
EN

Courts of Basel-Stadt have revoked bankruptcy of Kinarus Therapeutics Holding AG

29 Januar 2024

07:10 Ad-hoc EN

Kinarus Therapeutics Holding AG

Ad-hoc
EN

Kinarus Therapeutics Holding AG in Liquidation and Curatis AG propose to combine companies and reverse bankruptcy procedures of Kinarus Therapeutics Holding AG in Liquidation

25 September 2023

07:00 Ad-hoc EN

Kinarus Therapeutics Holding AG

Ad-hoc
EN

Kinarus Therapeutics has decided to file for bankruptcy

30 August 2023

18:00 Ad-hoc EN

Kinarus Therapeutics Holding AG

Ad-hoc
EN

Kinarus Therapeutics Group Reports First Half 2023 Financial Results

25 August 2023

18:00 Ad-hoc EN

Kinarus Therapeutics Holding AG

Ad-hoc
EN

Kinarus Therapeutics signed licensing agreement to extend cash for operations

12 Juli 2023

07:00 Corporate EN

Kinarus Therapeutics Holding AG

Corporate
EN

Kinarus Therapeutics Announces Personnel Changes

29 Juni 2023

18:00 Corporate EN

Kinarus Therapeutics Holding AG

Corporate
EN

Kinarus Therapeutics Shareholders Approve All Board Proposals at the 2023 Annual General Meeting

27 Juni 2023

07:00 Ad-hoc EN

Kinarus Therapeutics Holding AG

Ad-hoc
EN

Kinarus Therapeutics signed subordinated bridge loans to ensure further liquidity

2 Juni 2023

08:00 Corporate EN

Kinarus Therapeutics Holding AG

Corporate
EN

Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting

31 Mai 2023

07:00 Ad-hoc EN

Kinarus Therapeutics Holding AG

Ad-hoc
EN

Kinarus Therapeutics Group Reports 2022 Annual Results

11 Mai 2023

07:00 Ad-hoc EN

Kinarus Therapeutics Holding AG

Ad-hoc
EN

Kinarus Therapeutics signed CHF1.5 million convertible loan agreement with ChaoDian (Hangzhou) Investment Management

5 Mai 2023

07:00 Ad-hoc EN

Kinarus Therapeutics Holding AG

Ad-hoc
EN

Kinarus Therapeutics Reports Key Unaudited Full Year 2022 Figures

28 April 2023

07:00 Ad-hoc EN

Kinarus Therapeutics Holding AG

Ad-hoc
EN

Kinarus Therapeutics Holding AG (‘Kinarus’) receives deadline extension from SER for publication of its 2022 annual financial report

21 Februar 2023

07:00 Corporate EN

Kinarus Therapeutics Holding AG

Corporate
EN

Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical Trial Progress Update

17 Januar 2023

07:00 Corporate EN

Kinarus Therapeutics Holding AG

Corporate
EN

Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Plan

6 Dezember 2022

07:00 Corporate EN

Kinarus Therapeutics Holding AG

Corporate
EN

Kinarus Therapeutics’ KIN001 Shows Strong Antiviral Activity Against SARS-CoV-2 Omicron Subvariants BA.2 and BA.5

22 November 2022

07:00 Corporate EN

Kinarus Therapeutics Holding AG

Corporate
EN

Kinarus Receives USPTO Notice of Allowance for Lead Therapeutic Candidate KIN001

16 November 2022

07:00 Corporate EN

Kinarus Therapeutics Holding AG

Corporate
EN

Kinarus Therapeutics Engages Great Health Companion Group to Explore Partnerships in China

4 November 2022

14:05 Corporate EN

Kinarus Therapeutics Holding AG

Corporate
EN

Kinarus Therapeutics Provides Strategic Update

07:00 Corporate EN

Kinarus Therapeutics Holding AG

Corporate
EN

Kinarus Therapeutics Provides Strategic Update

30 September 2022

07:00 Ad-hoc EN

Kinarus Therapeutics Holding AG

Ad-hoc
EN

Kinarus Therapeutics Announces Discontinuation of the Phase 2 KINETIC Study of KIN001 in Hospitalized COVID-19 Patients Following a Prespecified Interim Analysis of Efficacy and Safety

31 August 2022

07:00 Ad-hoc EN

Kinarus Therapeutics Holding AG

Ad-hoc
EN

Kinarus Therapeutics Reports H1 2022 Financial Results and Provides Corporate Update

29 August 2022

07:00 Ad-hoc EN

Kinarus Therapeutics Holding AG

Ad-hoc
EN

Kinarus Therapeutics initiates KIN001 Phase II KINFAST clinical trial in COVID-19 outpatients

22 August 2022

07:06 Ad-hoc EN

Kinarus Therapeutics Holding AG

Ad-hoc
EN

Kinarus Therapeutics to hold webinar on a new approach to treating COVID-19

07:00 Ad-hoc EN

Kinarus Therapeutics Holding AG

Ad-hoc
EN

Kinarus announces the issuance of convertible notes of up to CHF 20 million to an entity managed by Yorkville

24 Juni 2022

07:01 Ad-hoc EN

Kinarus Therapeutics Holding AG

Ad-hoc
EN

Kinarus Therapeutics to host KOL event on Monday, June 27, to discuss therapies in wet Age-Related Macular Degeneration and potential advantages of KIN001

10 Juni 2022

07:00 Corporate EN

Kinarus Therapeutics Holding AG

Corporate
EN

Kinarus Therapeutics Announces Name Change and Commences Trading on the SIX Swiss Exchange under ticker “KNRS”

3 Juni 2022

07:00 Corporate EN

Kinarus Therapeutics Holding AG

Corporate
EN

Perfect Holding Completes Reverse Takeover Transaction with Kinarus

Anstehende Events

Keine Events gefunden